The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis

Journal of Cell Science

Volumn 119, Issue 12, 2006, Pages 2613-2620

  Christodoulides, Constantinos ^a   Laudes, Matthias ^a   Cawthorn, Will P ^a   Schinner, Sven ^a   Soos, Maria ^a   O'Rahilly, Stephen ^a   Sethi, Jaswinder K ^a   Vidal Puig, Antonio ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adipocyte; Adipogenesis; Dickkopf 1; Human; LRP5; Wnt

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; GENE PRODUCT; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MESSENGER RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ADIPOGENESIS; ADIPOSE TISSUE CELL; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS; CELL STRAIN 3T3; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TIME;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LDL-RECEPTOR RELATED PROTEINS; MICE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; WNT PROTEINS;

MURINAE;

EID: 33746032981     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02975     Document Type: Article

References (37)

1. Ai, M., Holmen, S. L., Van Hul, W., Williams, B. O. and Warman, M. L. (2005). Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol. Cell. Biol. 25, 4946-4955.
2. Bafico, A., Liu, G., Yaniv, A., Gazit, A. and Aaronson, S. A. (2001). Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol. 3, 683-686.
3. Bennett, C. N., Ross, S. E., Longo, K. A., Bajnok, L., Hemati, N., Johnson, K. W., Harrison, S. D. and MacDougald, O. A. (2002). Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277, 30998-31004.
4. Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K. and Lifton, R. P. (2002). High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513-1521.
5. Culbert, A. A., Brown, M. J., Frame, S., Hagen, T., Cross, D. A., Bax, B. and Reith, A. D. (2001). GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. FEBS Lett. 507, 288-294.
6. Davidson, G., Mao, B., del Barra Barrantes, I. and Niehrs, C. (2002). Kremen proteins interact with Dickkopf1 to regulate anteroposterior CNS patterning. Development 129. 5587-5596.
7. Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D. et al. (2001). LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development, Cell 107, 513-523.
8. Gregory, C. A., Singh, H., Perry, A. S. and Prockop, D. J. (2003). The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem. 278, 28067-28078.
9. Hagen, T. and Vidal-Puig, A. (2002). Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem. Biophys. Res. Commun. 294, 324-328.
10. Hagen, T., Sethi, J. K., Foxwell, N. and Vidal-Puig, A. (2004). Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem. J. 379, 471-477.
11. Jones, S. E. and Jomary, C. (2002). Secreted Frizzled-related proteins: searching for relationships and patterns. BioEssays 24, 811-820.
12. Kawano, Y. and Kypta, R. (2003). Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116, 2627-2634.
13. Laudes, M., Christodoulides, C., Sewter, C., Rochford, J. J., Considine, R. V., Sethi, J. K., Vidal-Puig, A. and O'Rahilly, S. (2004). Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J. Biol. Chem. 279, 11711-11718.
14. Little, R. D., Carulli, J. P., Del Mastro, R. G., Dupuis, J., Osborne, M., Folz, C., Manning, S. P., Swain, P. M., Zhao, S. C., Eustace, B. et al. (2002). A mutation in the LDL receptor-related protein 5 gene results in the amosomal dominant high-bonemass trait. Am. J. Hum. Genet. 70, 11-19.
15. Logan, C. Y. and Nusse, R. (2004). The Writ signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810.
16. Longo, K. A., Wright, W. S., Kang, S., Gerin, I., Chiang, S. H., Lucas, P. C., Opp, M. R. and MacDougald, O. A. (2004). Wntl0b inhibits development of white and brown adipose tissues. J. Biol. Chem. 279, 35503-35509.
17. MacDonald, B. T., Adamska, M. and Meisler, M. H. (2004). Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6. Development 131, 2543-2552.
18. MacDougald, O. A. and Mandrup, S. (2002). Adipogenesis: forces that tip the scales. Trends Endocrinol. Metab. 13, 5-11.
19. Mao, B. and Niehrs, C. (2003). Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302, 179-183.
20. Mao, B., Wu, W., Li, Y., Hoppe, D., Stannek, P., Glinka, A. and Niehrs, C. (2001). LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321-325.
21. Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C. et al. (2002). Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417, 664-667.
22. Miller, J. R. (2002). The Wnts. Genome Biol. 3, REVIEWS3001.
23. Moldes, M., Zuo, Y., Morrison, R. F., Silva, D., Park, B. H., Liu, J. and Farmer, S.R. (2003). Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem. J. 376, 607-613.
24. Nugent, C., Prins, J. B., Whitehead, J. P., Savage, D., Wentworth, J. M., Chatterjee, V. K. and O'Rahilly, S. (2001). Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol. Endocrinol. 15, 1729-1738.
25. Nuttall, M. E. and Gimble, J. M. (2004). Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr. Opin. Pharmacol. 4, 290-294.
26. Prockop, D. J., Gregory, C. A. and Spees, J. L. (2003). One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. USA 100 Suppl. 1, 11917-11923.
27. Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L. and MacDougald, O. A. (2000). Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953.
28. Ross, S. E., Erickson, R. L., Gerin, L, DeRose, P. M., Bajnok, L., Longo, K. A., Misek, D. E., Kuick, R., Hanash, S. M., Atkins, K. B. et al. (2002). Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol. Cell. Biol. 22, 5989-5999.
29. Semenov, M. V., Tamai, K., Brott, B. K., Kuhl, M., Sokol, S. and He, X. (2001). Head inducer Dickkopf-l is a ligand for Wnt coreceptor LRP6. Curr. Biol. 11, 951-961.
30. Sewter, C. P., Blows, F., Vidal-Puig, A. and O'Rahilly, S. (2002). Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists. Diabetes 51, 718-723.
31. Taipale, J. and Beachy, P. A. (2001). The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354.
32. Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B. and Shaughnessy, J. D., Jr (2003). The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N. Engl. J. Med. 349, 2483-2494.
33. Van Wesenbeeck, L., Cleiren, E., Gram, J., Beals, R. K., Benichou, O., Scopelliti, D., Key, L., Renton, T., Bartels, C., Gong, Y. et al. (2003). Six novel missense mutations in the LDL, receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet, 72, 763-771.
34. Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., 3rd and Nusse, R. (2003). Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448-452.
35. Wodarz, A. and Nusse, R. (1998). Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14, 59-88.
36. Xu, H., Sethi, J. K. and Hotamisligil, G. S. (1999). Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1. J. Biol. Chem. 274, 26287-26295.
37. Zhang, Y., Wang, Y., Li, X., Zhang, J., Mao, J., Li, Z., Zheng, J., Li, L., Harris, S. and Wu, D. (2004). The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol. Cell. Biol. 24, 4677-4684.